We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Scientists Create Model of Beating Heart Muscle

By Biotechdaily staff writers
Posted on 12 Aug 2002
A bioengineered, experimental model of rhythmically beating heart muscle has been produced by the collaborative effort of a cardiologist and an orthopedist at the University of North Carolina at Chapel Hill (UNC, USA). More...
They presented their model at the World Congress of Biomechanics in Calgary (Canada).

The model is a bioartificial trabeculum, or BAT. Trabecula are thin sections of cardiac tissue within the inner surface of the main pumping chambers of the heart. The model may prove to be a valuable tool for exploring cardiac disease or to generate tissue patches that might be applied to the surface of the heart or incorporated into a diseased heart as therapy.

Dr.Albert J. Banes, UNC professor of orthopedics, had earlier developed a special tissue plate used as a framework in which cells in a liquid collagen gel could remodel to form a more tissue-like structure. "We thought it would be better to grow cells in a dynamic environment, on a flexible substrate.”

Dr. Wayne E. Cascio, UNC associate professor of medicine, thought they could grow cardiac myocytes and make a cardiac muscle tissue-like material to test in culture. In developing the tissue model, Dr. Cascio and an assistant isolated cardiac myocytes from one-day-old rats. These were mixed in a solution of collagen and serum and allowed to gel under incubation in the special tissue plate developed by Dr. Banes. After four days in culture, the heart cells migrated toward the center of the gel to form a dense cord of tissue that extended between two tethers.

The tissue strand rhythmically contracts at 100 beats per minute, easily observed with a low-power microscope, say the researchers. Tests reveal striations and cell-to-cell coupling characteristic of cardiac tissue. "In my lab, we're specifically interested in generating cardiac myocytes with certain electrical or contractile properties by manipulating the genetics of the cells and then reforming them into functional tissue to assess their properties,” said Dr. Cascio.




Related Links:
University of North Carolina

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
All-in-One Molecular System
AIO M160
New
Silver Member
Connectivity Solution
EKF Link
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.